Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes

Transplantation

Volumn 68, Issue 6, 1999, Pages 894-900

  Baldwin III, William M ^a   Samaniego Picota, Milagros ^a   Kasper, Edward K ^a   Clark, Adam M ^b   Czader, Magdalena ^a   Rohde, Charles ^b   Zachary, Andrea A ^a   Sanfilippo, Fred ^a   Hruban, Ralph H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; ISCHEMIA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; BIOPSY; CARDIOPULMONARY BYPASS; COMPLEMENT C3D; COMPLEMENT C4; COMPLEMENT C4B; COMPLEMENT SYSTEM PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MYOCARDIUM; PARAFFIN EMBEDDING; PEPTIDE FRAGMENTS; REPERFUSION INJURY; TIME FACTORS;

EID: 0033610274     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199909270-00024     Document Type: Article

References (39)

1. van Es A, Hermans J, van Bockel JH, Persijn GG, van Hooff JP, de Graeff J. Effect of warm ischemia time and HLA (A and B) matching on renal cadaveric graft survival and rejection episodes. Transplantation 1983; 36: 255.
2. Sanfilippo F, Vaughn WK, LeFor WM, Spees EK. Multivariate analysis of risk factors in cadaver donor kidney transplantation. Transplantation 1986; 42: 28.
3. Halloran PF, Aprile MA, Farewell V, et al. Early function as the principal correlate of graft survival: a multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988; 46: 223.
4. Gaudin PB, Rayburn BK, Hutchins GM, et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol. 1994; 18: 338.
5. Hruban RH, Baldwin WM III, Sanfilippo F. Immunopathology of rejection. In: Solez K, Racusen LC, Billingham M, eds. Pathology and rejection diagnosis in solid organ allografts. New York: Marcel Dekker, 1995: 59.
6. Yilmaz S, Paavonen T, Hayry P. Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Transplantation 1992; 53: 823.
7. Opelz G, Wujciak T. The influence of HLA compatibility on graft survival after heart transplantation. N Engl J Med 1994; 330: 816.
8. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
9. Maroko PR, Carpenter CD, Chiariello M, et al. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest 1978; 61: 661.
10. Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249: 146.
11. Halloran PF, Autenried P, Ramassar V, Urmson J, Cockfield S. Local T cell responses induce widespread MHC expression: evidence that IFNy induces its own expression in remote sites. J Immunol 1992; 148: 3837.
12. Kilgore KS, Friedrichs GS, Homeister JW, Lucchesi BR. The complement system in myocardial ischemia/reperfusion injury. Cardiovasc Res 1994; 28: 437.
13. Weiser MR, Williams JP, Moore FD Jr, et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996; 183: 2343.
14. Ibrahim S, Sroka N, Zukin Y, et al. Immunohistochemical manifestations of unilateral kidney ischemia. Clin Transplant 1996; 10: 646.
15. Azuma H, Nadeau K, Mackenzie HS, Brenner BM, Tilney NL. Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 1997; 63: 519.
16. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682.
17. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 100: 1199.
18. Ollert MW, Kadlec JV, David K, Petrella EC, Bredehorst R, Vogel CW. Antibody-mediated complement activation on nucleated cells: a quantitative analysis of the individual reaction steps. J Immunol 1994; 153: 2213.
19. Kilgore KS, Flory CM, Miller BF, Evans VM, Warren JS. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 1996; 149: 953.
20. Berry GJ, Brunt EM, Chamberlain D, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group; The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 593.
21. Zachary AA, Klingman L, Thorne N, Smerglia AR, Teresi GA. Variations of the lymphocytotoxicity test: an evaluation of sensitivity and specificity. Transplantation 1995 60: 498.
22. Mollnes TE. Biocompatibility: complement as mediator of tissue damage and as indicator of incompatibility. Exp Clin Immunogenet 1997; 14: 24.
23. Moen O, Fosse E, Dregelid E, et al. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg 1996; 62: 1134.
24. Ashraf S, Butler J, Tian Y, et al. Inflammatory mediators in adults undergoing cardiopulmonary bypass: comparison of centrifugal and roller pumps. Ann Thorac Surg 1998; 65: 480.
25. Yasojima K, Schwab C, McGeer EG, McGeer PL. Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res 1998; 83: 860.
26. Herijgers P, Leunens V, Tjandra-Maga T, Mubagwa K, Flamen GW. Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines. Transplantation 1996; 62: 330.
27. Novitzky D, Rhodin J, Cooper DK, Ye Y, Min KW, DeBault L. Ultrastructure changes associated with brain death in the human donor heart. Transplant Int 1997; 10: 24.
28. Baroldi G, Di Pasquale G, Silver MD, Pinelli G, Lusa AM, Fineschi V. Type and extent of myocardial injury related to brain damage and its significance in heart transplantation: a morphometric study. J Heart Lung Transplant 1997; 16: 994.
29. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: evidence for neutrophil-mediated reperfusion injury. Circulation 1989; 80: 1816.
30. Kagiyama A, Savage HE, Michael LH, Hanson G, Entman ML, Rossen RD. Molecular basis of complement activation in ischemic myocardium: identification of specific molecules of mitochondrial origin that bind human C1q and fix complement. Circ Res 1989; 64: 607.
31. Kovacsovics TJ, Peitsch MC, Kres A, Isliker H. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles. J Immunol 1987; 138: 1864.
32. Pemberton M, Anderson G, Vetvicka V, Justus DE, Ross GD. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol 1993; 150: 5104.
33. Baldwin WM III, Ibrahim S, Kasper E, Sanfilippo F, Hruban RH. Complement deposition in early cardiac transplant biopsies is associated with warm ischemic injury. J Heart Lung Transplant 1997; 16: 45.
34. Feucht HE, Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 1996; 50: 1464.
35. Qian Z, Wasowska B, Behrens E, et al. C6 produced by macrophages contributes to cardiac allograft rejection. Am J Pathol (in press).
36. Linas SL, Whittenburg D, Parsons PE, Repine JE. Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int 1992; 42: 610.
37. Seekamp A, Mulligan MS, Till GO, Ward PA. Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. Am J Pathol 1993; 142: 1217.
38. Baldwin WM III, Pruitt SK, Brauer RB, Daha MR, Sanfilippo F. Complement in organ transplantation: contribution to inflammation, injury and rejection. Transplantation 1995; 59: 797.
39. Engelman RM, Rousou JA, Flack JE III, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 801.